logo
logo

Series A Financing Round Lays Foundation For International Growth Of Digital Cancer Therapeutics Mika

Series A Financing Round Lays Foundation For International Growth Of Digital Cancer Therapeutics Mika

05/09/22, 6:54 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/HK.svghong kong
Industry
energy
sustainability
lending and investments
data and analytics
information technology
education
financial services
Round Type
series a
Berlin-based digital health company Fosanis, the developer of Mika, Germany's first prescription DTx for all oncological indications, closed a series A funding round of more than 10 million EUR. Besides existing shareholders such as Ananda Impact Ventures, three new investors joined in the latest financing round: lead investor Swiss company Debiopharm Innovation Fund, Ship2B Ventures from Spain and venture capital firm Equity Pitcher.

Company Info

Company
Aria
Location
hong kong
Additional Info
The company is currently building an ESG ecosystem based on 3 key pillars, namely GoLearn (education), GoNetwork (structured advocacy) and GoInvest (deal flow platform for sustainable investments), to enable actions on sustainable development.

Related People